Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Wyeth-Ayerst and Elan develop new formulation of Lodine

April 11, 1997

NitroMed/J&J divisions collaborate on NSAID/NO donor compounds

April 9, 1997

Pivotal trial of Therafectin enrolled

April 3, 1997

Wyeth-Ayerst describes antiinflammatory agents

April 2, 1997

Protein Design Labs grants license to IDEC for humanized MAb

March 25, 1997

Antiinflammatory protein described by New York University

March 25, 1997

Fujisawa describes compound for autoimmune diseases

March 24, 1997

Nippon Shinyaku discloses cell adhesion inhibitors

March 21, 1997

JT characterizes novel COX-2 inhibitor

March 19, 1997

COX-2 inhibitors disclosed by Hafslund Nycomed

March 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....